The pharmaceutical company filed an antitrust lawsuit against Eli Lilly and Novo Nordisk. The lawsuit concerns the growing market for weight loss drugs. She accused them of using anti-competitive tactics. The lawsuit is part of the latest spat in the market. The compounding pharmacy says the companies are hindering competition. The details of the tactics are not further specified in the article.[1][2]